Emergency Department-based Self-Sampling for Cervical Cancer Screening in Women and TransgenderNon-binary Individuals Aged 30 to 65

What this Trial Is About

Researchers are evaluating the use of self-sampling for cervical cancer screening in the emergency department ED among women and transgendernon-binary individuals with a cervix aged 30 to 65 years. This single-arm pilot trial aims to compare how many patients complete cervical cancer screening through HPV self-sampling during their ED visit, addressing barriers to care and participant experiences with this method. Follow-up will assess screening activity and related outcomes about 150 days after enrollment. Participants will be given instructions on how to self-sample for HPV using a swab during their ED visit. They can perform the sample collection privately, either in their ED room or a private restroom. After sampling, the swabs are sent to a laboratory for analysis. Those who choose not to or cannot complete self-sampling will still remain in the study and be referred for clinic-based screening. Participants who are already adherent to screening guidelines will have their participation ended after a screening survey. During the study, participants will complete a survey and follow-up at 150 days will gather information on cervical cancer screening activity, barriers to care, and experiences with the intervention. Researchers will review electronic health records to verify screening activities and clinical testing completion. The primary outcome is the uptake of cervical cancer screening through self-sampling in the ED, monitored approximately 150 days after enrollment.

Emergency Department-based Cervical Cancer Screening Through Self-sampling